Cargando…
How to design a dose-finding study on combined agents: Choice of design and development of R functions
BACKGROUND: In oncology, the aim of dose-finding phase I studies is to find the maximum tolerated dose for further studies. The use of combinations of two or more agents is increasing. Several dose-finding designs have been proposed for this situation. Numerous publications have however pointed out...
Autor principal: | Ezzalfani, Monia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844553/ https://www.ncbi.nlm.nih.gov/pubmed/31710632 http://dx.doi.org/10.1371/journal.pone.0224940 |
Ejemplares similares
-
Dose-finding designs using a novel quasi-continuous endpoint for multiple toxicities
por: Ezzalfani, Monia, et al.
Publicado: (2013) -
Bayesian dose-finding designs for combination of molecularly targeted agents assuming partial stochastic ordering
por: Guo, Beibei, et al.
Publicado: (2014) -
Modern dose-finding designs for cancer phase I trials: drug combinations and molecularly targeted agents
por: Hirakawa, Akihiro, et al.
Publicado: (2018) -
How to design a dose-finding study using the continual reassessment method
por: Wheeler, Graham M., et al.
Publicado: (2019) -
Efficiency of New Dose Escalation Designs in Dose-Finding Phase I Trials of Molecularly Targeted Agents
por: Le Tourneau, Christophe, et al.
Publicado: (2012)